These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 18161397)
21. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Giuntoli RL; Garrett-Mayer E; Bristow RE; Gostout BS Gynecol Oncol; 2007 Jul; 106(1):82-8. PubMed ID: 17434579 [TBL] [Abstract][Full Text] [Related]
22. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors. Fadare O; Liang SX Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203 [TBL] [Abstract][Full Text] [Related]
23. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas. Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902 [TBL] [Abstract][Full Text] [Related]
24. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Atkins KA; Arronte N; Darus CJ; Rice LW Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776 [TBL] [Abstract][Full Text] [Related]
26. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases. Burns B; Curry RH; Bell ME Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641 [TBL] [Abstract][Full Text] [Related]
27. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors. Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171 [TBL] [Abstract][Full Text] [Related]
28. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma. Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023 [TBL] [Abstract][Full Text] [Related]
29. Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature. Vilos GA; Marks J; Ettler HC; Vilos AG; Prefontaine M; Abu-Rafea B J Minim Invasive Gynecol; 2012; 19(3):288-95. PubMed ID: 22546421 [TBL] [Abstract][Full Text] [Related]
30. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics. Watanabe K; Suzuki T Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782 [TBL] [Abstract][Full Text] [Related]
31. Clinical update of smooth muscle tumors of the uterus. Solomon LA; Schimp VL; Ali-Fehmi R; Diamond MP; Munkarah AR J Minim Invasive Gynecol; 2005; 12(5):401-8. PubMed ID: 16213425 [TBL] [Abstract][Full Text] [Related]
32. Borderline smooth muscle tumors of the uterus. Mulayim N; Gucer F Obstet Gynecol Clin North Am; 2006 Mar; 33(1):171-81. PubMed ID: 16504814 [TBL] [Abstract][Full Text] [Related]
33. Smooth Muscle Tumors of the Female Genital Tract. Devereaux KA; Schoolmeester JK Surg Pathol Clin; 2019 Jun; 12(2):397-455. PubMed ID: 31097110 [TBL] [Abstract][Full Text] [Related]
34. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation. Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095 [TBL] [Abstract][Full Text] [Related]
36. Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization. Kainsbak J; Hansen ES; Dueholm M Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():130-7. PubMed ID: 26117442 [TBL] [Abstract][Full Text] [Related]
37. Smooth Muscle Tumors of the Visceral Adnexal and Uterine Ligaments and Adnexal Connective Tissue: A Clinicopathologic Study of 67 Cases. Patel V; Xing D; Feely M; Schoolmeester JK Int J Gynecol Pathol; 2020 Jan; 39(1):55-67. PubMed ID: 30702465 [TBL] [Abstract][Full Text] [Related]
38. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389 [TBL] [Abstract][Full Text] [Related]
39. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study. Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029 [TBL] [Abstract][Full Text] [Related]
40. Intraoperative Frozen Section Biopsy of Uterine Smooth Muscle Tumors: A Clinicopathologic Analysis of 112 Cases With Emphasis on Potential Diagnostic Pitfalls. Lok J; Tse KY; Lee EYP; Wong RWC; Cheng ISY; Chan ANH; Leung CKL; Cheung ANY; Ip PPC Am J Surg Pathol; 2021 Sep; 45(9):1179-1189. PubMed ID: 34074809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]